The short answer
High-dose vitamin E may add to bleeding risk with warfarin, particularly when vitamin K intake is low. The evidence does not establish a universal supplement threshold. A small randomized trial found no significant INR change, while observational vitamin E blood levels were associated with bleeding. Those different findings should not be collapsed into a claim that every vitamin E dose causes harm.
What this answer covers
Oral vitamin E supplementation with oral warfarin. Vitamin E forms and doses differ; a serum vitamin E association is not equivalent to a trial of a particular supplement.
- Supplement or preparation
- Vitamin E
- Medication ingredient
- warfarin
What does the evidence show?
NIH's Office of Dietary Supplements identifies a potential bleeding interaction at large vitamin E doses and notes uncertainty about the amount needed for a clinically important effect. A randomized study of 21 warfarin users found no significant INR change, but its retrieved abstract did not provide sufficient dose and duration detail to define a threshold. A 566-patient observational study linked higher serum vitamin E to bleeding. It measured nutrient status rather than assigning supplements, so causation and dose cannot be inferred.
Which forms and conditions matter?
Check both the chemical form and the amount per serving. A generic vitamin E label can refer to different tocopherol preparations, and units on older studies may not match a current label's milligrams. The evidence does not justify translating a serum concentration into a recommended supplement dose or treating food intake as equivalent to high-dose capsules.
What should I discuss with my care team?
Ask the anticoagulation clinician before adding a high-dose vitamin E supplement or changing an existing product. Review the complete multivitamin and supplement list to avoid missing overlapping vitamin E. The clinician can assess bleeding history, diet and INR monitoring. Taking vitamin E several hours apart from warfarin is not a demonstrated way to eliminate the proposed clotting effect.
How certain is the answer?
A neutral INR result in a small trial does not exclude every platelet-related bleeding effect. Conversely, a nutrient-status association does not prove that supplements caused the observed bleeding. The supported precaution is conditional on exposure and patient factors; neither a guaranteed safe dose nor a numerical individual bleeding risk is established here.
Evidence and practical considerations
Side effects & toxicity
High-dose vitamin E may add to bleeding risk with warfarin, particularly when vitamin K intake is low. The evidence does not establish a universal supplement threshold. A small randomized trial found no significant INR change, while observational vitamin E blood levels were associated with bleeding. Those different findings should not be collapsed into a claim that every vitamin E dose causes harm.
- Exact scope
- Oral vitamin E supplementation with oral warfarin. Vitamin E forms and doses differ; a serum vitamin E association is not equivalent to a trial of a particular supplement. with Oral warfarin, including warfarin sodium tablets with the warfarin active moiety.
- Medication form and route
- oral warfarin
- Timing or duration
- Study-specific durations are described in each source exposure; no universally safe exposure duration has been established.
What remains uncertain
- A neutral INR result in a small trial does not exclude every platelet-related bleeding effect. Conversely, a nutrient-status association does not prove that supplements caused the observed bleeding. The supported precaution is conditional on exposure and patient factors; neither a guaranteed safe dose nor a numerical individual bleeding risk is established here.
Factors that may matter: Exact supplement preparation and other ingredients; Starting, stopping or changing supplement intake; Baseline anticoagulation control and clinician-supervised monitoring.
Read the supporting source summaries
Source 1: current U.S. regulatory prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed oral warfarin sodium tablets.
The label advises closer INR monitoring when botanicals are started or stopped, identifies variable botanical composition and lists selected potential interactions. Vitamin K intake should remain consistent.
How this applies: Oral warfarin sodium has warfarin as its active moiety. Label-level botanical and vitamin K monitoring advice applies; it is not proof of this exact supplement effect. Oral vitamin E supplementation with oral warfarin. Vitamin E forms and doses differ; a serum vitamin E association is not equivalent to a trial of a particular supplement.
Regulatory precautions do not quantify the incidence for every exact preparation or prove an interaction for an unlisted ingredient. Warfarin sodium is bridged to the warfarin active moiety only for the oral product.
Source 2: government clinical reference
ods.od.nih.gov · Source check Sep 10, 2026
Population: People using vitamin E supplements with anticoagulant or antiplatelet medicines.
The reference describes possible increased bleeding, especially when vitamin K intake is low, while stating that the clinically important amount is uncertain.
How this applies: General warfarin monitoring guidance applies to this pair; the exact-pair conclusion relies on the source-specific evidence and limitations below. Exact package scope: Oral vitamin E supplementation with oral warfarin. Vitamin E forms and doses differ; a serum vitamin E association is not equivalent to a trial of a particular supplement.
Guidance and evidence synthesis, not an exact-pair dose-finding trial. The suggested dose range must not be treated as a verified safe threshold.
Source 3: peer-reviewed original research
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 21 people taking chronic warfarin randomized to vitamin E or placebo.
No significant INR change occurred in the vitamin E group.
How this applies: Direct vitamin E plus warfarin trial. Neutral INR is not comprehensive testing of platelet-mediated bleeding. Exact package scope: Oral vitamin E supplementation with oral warfarin. Vitamin E forms and doses differ; a serum vitamin E association is not equivalent to a trial of a particular supplement.
Small trial; the available abstract cannot establish a dose threshold, bleeding risk or safety for all vitamin E products.
Source 4: peer-reviewed original research
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 566 anticoagulated adults with nonvalvular atrial fibrillation, followed for an average 22 months.
Higher baseline vitamin E was associated with subsequent bleeding events during warfarin treatment.
How this applies: Vitamin E blood-status association in warfarin users is indirect for a supplement intervention; dose and causal effects cannot be inferred. Exact package scope: Oral vitamin E supplementation with oral warfarin. Vitamin E forms and doses differ; a serum vitamin E association is not equivalent to a trial of a particular supplement.
Nutrient-status association does not establish that taking a specified vitamin E supplement causes bleeding or define a supplement dose threshold.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Original evidence and contradictory findings assessed for this exact pair. Article drafted and existing statements adjudicated. Clinical sign-off has not been recorded. | |
| Research summary published |
Article revision: 545d4343d44cadd3
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.